These observations suggest that the presence of CD68 + CLS-B vs hCLS-B may reflect different biologic responses to obesity – the former characterised by insulin resistance and poor breast cancer outcomes and the latter by metabolic health with no evidence of adverse outcomes. The gene discussed is CD68; the disease is obesity due to melanocortin 4 receptor deficiency.